Family Medicine · Pennsville, NJ
NPI
1902805013
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
181 N Broadway
Pennsville, NJ, 08070
Phone (856) 678-9002
Medicare paid, 2024
$251K
3,785 services
Medicare patients, 2024
803
Average age 75
Drug cost, 2024
$1.4M
17,607 prescriptions
Company payments, 2025
$46.03
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell Bober was code 99213 (office e&m - established), 1,434 times for 625 patients. In total Mitchell Bober billed 3,785 services in 44 codes, and Medicare paid $251K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,434 | 625 | $60.80 | $87K |
| 99214 Office E&M - Established | Office | 871 | 494 | $85.22 | $74K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 422 | 11 | $0.09 | $38.93 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 320 | 320 | $124.14 | $40K |
| 93000 Electrocardiogram | Office | 101 | 95 | $9.84 | $994 |
| G0008 Administration of influenza virus vaccine | Office | 100 | 98 | $34.22 | $3,422 |
| 90662 Vaccine Product | Office | 98 | 96 | $81.11 | $7,949 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 46 | 43 | $158.38 | $7,286 |
| 69210 Other Organ Systems | Office | 36 | 32 | $28.56 | $1,028 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 35 | 35 | $157.98 | $5,529 |
| 90677 Vaccine Product | Office | 33 | 33 | $292.08 | $9,639 |
| G0009 Administration of pneumococcal vaccine | Office | 33 | 33 | $34.22 | $1,129 |
| 99204 Office E&M - New | Office | 27 | 27 | $109.28 | $2,951 |
| 96372 Injection Administration | Office | 25 | 12 | $10.99 | $275 |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 22 | 20 | $6.73 | $148 |
By year: 2022 $213K for 3,491 services; 2023 $235K for 3,218 services; 2024 $251K for 3,785 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell Bober prescribed most often to Medicare patients was Losartan Potassium, with 1,202 prescriptions and refills. In total Mitchell Bober wrote 17,607 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 1,202 | 3,145 | 292 | $11K |
| Atorvastatin Calcium Generic | 1,003 | 2,625 | 261 | $8,700 |
| Amlodipine Besylate Generic | 955 | 2,456 | 243 | $5,937 |
| Metformin Hcl Generic | 677 | 1,737 | 175 | $5,857 |
| Levothyroxine Sodium Generic | 563 | 1,547 | 142 | $5,560 |
| Metoprolol Succinate Generic | 556 | 1,477 | 152 | $8,672 |
| Pantoprazole Sodium Generic | 530 | 1,163 | 144 | $5,940 |
| Glimepiride Generic | 389 | 940 | 102 | $3,848 |
| Omeprazole Generic | 382 | 1,006 | 102 | $4,838 |
| Lisinopril Generic | 372 | 1,049 | 102 | $2,445 |
| Pravastatin Sodium Generic | 362 | 992 | 92 | $4,173 |
| Simvastatin Generic | 316 | 878 | 87 | $3,547 |
| Furosemide Generic | 267 | 495 | 81 | $940 |
| Citalopram Hbr Citalopram Hydrobromide | 248 | 593 | 56 | $1,613 |
| Rosuvastatin Calcium Generic | 245 | 661 | 70 | $3,367 |
Brand drugs: 2,027 claims; generic drugs: 15,416 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell Bober $46.03 ($46.03 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $30.96.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.